Advertisement

Pituitary-adrenal responses to dexamethasone and CRH administration in patients with untreated Parkinson’s disease

  • E. Martignoni
  • A. Costa
  • R. E. Nappi
  • C. Pacchetti
  • L. Godi
  • G. Nappi
Article
  • 11 Downloads

Keywords

Cortisol Melancholia HRSD Score High Baseline Cortisol Mesocortical Dopaminergic System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Javoy-Agid F., Agid Y.: Is the mesocortical dopaminergic system involved in Parkinson’s disease? Neurology 30: 1326–1330, 1980.PubMedCrossRefGoogle Scholar
  2. 2.
    Javoy-Agid F., Ruberg M., Taquet H., Bokobza B., Agid Y., Gaspar P., Berger B., N’Guyen-Legros J., Alverez C., Escourolle R., Scatton B., Rouquier L.: Biochemical neuropathology of Parkinson’s disease. In: Hassler R.G., Christ J.F. (Eds.), Advances in neurology, vol. 40. Raven Press, New York, 1984, pp. 189–198.PubMedGoogle Scholar
  3. 3.
    Pfeiffer R.F., Hsieh H.H., Djercks M.J., Glaeske C., Jefferson A., Cheng S.C.: Dexamethasone suppression test in Parkinson’s disease. In: Yahr M.D., Bergmann K.S. (Eds.), Advances in neurology, vol.45. Raven Press, New York, 1986, pp. 439–442.Google Scholar
  4. 4.
    Rabey J.M., Scharf M., Oberman Z., Zohar M., Graff E.: Cortisol, ACTH and Beta-endorphin after dexamethasone administration in Parkinson’s dementia. Biol. Psychiatry 27: 581–591, 1990.PubMedCrossRefGoogle Scholar
  5. 5.
    Bellomo G., Santambrogio L., Fiacconi M., Scarponi A.M., Ciuffetti G.: Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson’s disease. J. Neurol 238: 19–22, 1991.PubMedCrossRefGoogle Scholar
  6. 6.
    Volpi R., Caffarra P., Marcato A., Scaglioni A., Maestri D., Del Signore R., Chiodera P., Coiro V.: Reduced ACTH/ Cortisol responses to naloxone in men with Parkinson’s disease. J. Neural Transm. (P-D Sect) 3: 127–132, 1991.CrossRefGoogle Scholar
  7. 7.
    Volpi R., Caffarra P., Scaglioni A., Saginario A., Maestri D., Vourna S., Vescovi.PP., Chiodera P., Coiro V.: Lack of ACTH/Cortisol and GH responses to intravenously-infused substance P in Parkinson’s disease. J. Neural Transm. (P-D Sect) 6: 99–107, 1993.CrossRefGoogle Scholar
  8. 8.
    Carrol B.J., Feinberg M., Greden J.F., Tarika J., Albalav A.A., Haskett R.F., James N.McI., Kronfol Z., Lohr N., Steiner M., de Vigne J.P., Young E.: A specific laboratory test for the diagnosis of melancholia. Arch. Gen. Psychiatry 38: 15–22, 1981.CrossRefGoogle Scholar
  9. 9.
    Martignoni E., Costa A., Sinforiani E., Liuzzi A., Chiodini P.G., Mauri M., Bono G., Nappi G.: The brain as a target for adrenocortical steroids: cognitive implications. Psychoneuroendocrinology 4: 343–354, 1992.CrossRefGoogle Scholar
  10. 10.
    Davis K.L., Davies M.D., Mathé A.A., Mohs R.C., Rothpearl A.B., Lewy M., Gorman L.K., Berger P.: Age and dexamethasone suppression test in depression. Am. J. Psychiatry 141: 872-874, 1984.Google Scholar

Copyright information

© Springer Internal Publishing Switzerland 1997

Authors and Affiliations

  • E. Martignoni
    • 1
  • A. Costa
    • 2
  • R. E. Nappi
    • 1
  • C. Pacchetti
    • 1
  • L. Godi
    • 1
  • G. Nappi
    • 1
  1. 1.Centre for Parkinson’s disease Centre for Parkinson’s disease - Institute of Neurology “C. Mondino”University of PaviaPaviaItaly
  2. 2.Lab. of Neuroendocrinology, Institute of Neurology “C. Mondino”University of PaviaPaviaItaly

Personalised recommendations